Forian Inc. (: FORA)

Forian is a leading provider of data science-driven information and analytics solutions to the life sciences, healthcare and financial services industries. The company leverages its expertise in data management and data science to cleanse, link and enhance structured and unstructured data points to generate information products that optimize operational, clinical and financial performance for customers. Forian creates data-based subscription products that serve a wide breadth of use across the fragmented U. S. healthcare ecosystem.

Forian generates revenue through subscription and services-based solutions that provide access to its proprietary data factory and analytics platforms. The company offers innovative commercial, real world evidence (RWE) and market access solutions, as well as customized or productized information products directly to end users and through service provider partnerships. A significant portion of revenue is derived from multi-year contracts for information products that are updated over time, with additional revenue from one-time custom reports for specific analytic needs.

Forian operates through the following segments: life sciences, healthcare and financial services.

• Life sciences: This segment provides data management capabilities and proprietary enriched information and analytics solutions to pharmaceutical and biotechnology companies. It focuses on commercial analytics, real world evidence and market access solutions to support drug development and commercialization strategies. The segment helps clients understand therapeutic efficacy, patient journeys and market dynamics through linked data assets.

• Healthcare: This segment serves healthcare payers and providers with solutions that optimize operational, clinical and financial performance. It delivers data-driven insights for risk stratification, treatment protocol development and value-based contracting initiatives. The segment supports providers in enhancing care delivery and payers in managing healthcare costs through analytics-ready data products.

• Financial services: This segment offers healthcare information products and solutions to hedge funds, mutual funds, pension funds and similar investment funds. It provides proprietary clinical and commercial data products to enable informed investment decisions in U. S. healthcare, biotechnology and pharmaceutical companies. The segment leverages Forian’s data factory to deliver actionable intelligence for portfolio managers investing in healthcare sectors.

Forian holds a competitive position in the healthcare analytics market through its proprietary data factory and linked longitudinal database encompassing the majority of the U. S. population. The company differentiates itself from competitors such as IQVIA, ICON plc, Veeva Systems and Definitive Healthcare Corp by offering flexible, scalable privacy-focused analytics with deep domain expertise in life sciences and healthcare economics. Its ability to integrate disparate data sources into actionable insights provides a unique advantage in serving stakeholders across the patient journey.

Forian serves a diverse customer base across life sciences, healthcare payer and provider organizations, and financial services institutions including hedge funds, mutual funds and pension funds. The company’s solutions are used by pharmaceutical manufacturers, physicians, caregivers, payers, patients, consultants and service providers seeking to improve clinical and commercial performance through data-driven decision making.